Table 2 Baseline patient characteristics at trial entry
| Â | Intervention n = 31 | Control n = 25 | Total n = 56 |
|---|---|---|---|
Mean age (SD) | 76.5 (3.7) | 76.4 (5.2) | 76.4 (4.4) |
Number of prescribed medicationsa mean (SD) | 6.8 (1.9) | 6.6 (2.1) | 6.7 (2.0) |
Medical conditions (current or previous)bn (%) | |||
 Cardiovascular | 19 (61.3) | 23 (92.0) | 42 (75.0) |
 Central nervous | 2 (6.5) | 5 (20.0) | 7 (12.5) |
 Gastro-intestinal | 6 (19.4) | 3 (12.0) | 9 (16.1) |
 Respiratory | 4 (12.9) | 2 (8.0) | 6 (10.7) |
 Ocular | 1 (3.2) | 1 (4.0) | 2 (3.6) |
 Urogenital | 9 (29.0) | 3 (12.0) | 12 (21.4) |
 Endocrine | 9 (29.0) | 3 (12.0) | 12 (21.4) |
 Musculoskeletal | 8 (25.8) | 7 (28.0) | 15 (26.8) |
 Other | 17 (54.8) | 10 (40.0) | 27 (48.2) |
Allergy/intolerancecn (%) | |||
 Yes | 9 (29.0) | 8 (32.0) | 17 (30.4) |
 No | 22 (71.0) | 17 (68.0) | 39 (69.6) |